Prognostic factors in patients with septic disseminated intravascular coagulation treated with thrombomodulin: the effect of reduced thrombomodulin dose; a single-center, retrospective, observational study

BACKGROUND: Human soluble recombinant thrombomodulin (TM alfa), a treatment for septic Disseminated intravascular coagulation (DIC), is recommended for patients with severe renal dysfunction in reduced doses. However, no studies have examined yet how dose reduction affects clinical efficacy. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishita, Yoshihiro, Taga, Masatoshi, Sakurai, Masaru, Iinuma, Yoshitsugu, Masauji, Togen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743769/
https://www.ncbi.nlm.nih.gov/pubmed/36503588
http://dx.doi.org/10.1186/s40780-022-00264-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743769/
https://www.ncbi.nlm.nih.gov/pubmed/36503588
http://dx.doi.org/10.1186/s40780-022-00264-9

Ejemplares similares